Haddad5 found no increase in plasma 25-hydroxyvitamin D (25-OHD) levels with oral vitamin D3 supplements until after 36 weeks' gestational age, whereas Wolf et al. 6 reported an increase in plasma 25-OHD in response to oral vitamin D3 at 32-34 weeks. We report plasma 25-OHD levels in 18 preterm babies receiving supplements of either 400 Plasma 25-hydroxyvitamin D concentrations in preterm infants receiving oral vitamin D supplements 145 group 2 (45 2±4 7) was higher than that in group 1 (35 * 0±3 * 8 nmol/l; P = NS). There was a significant correlation between the plasma 25-OHD level at day 14 and the percentage rise at 36 weeks (r = -0-68, P<0i 0025) (Fig. 2) . Plasma 25-OHD levels measured at 39 weeks were similar to those found at 36 weeks (38&9 ± 5-1 in group 1 and 37 6 ± 2 7 nmol/l in group 2). No significant changes in plasma calcium or alkaline phosphatase occurred during vitamin D supplementation; plasma calcium at 14 days was normal in all but one infant, who was hypocalcaemic (1-74 mmol/l; 7 0 mg/100 ml), and all alkaline phosphatase levels were normal. No infant showed radiological evidence of rickets.
Comment
We have shown that oral supplementation with 400 or 1000 IU of vitamin D3 daily produces a significant rise in plasma 25-OHD levels by 36 weeks in preterm babies without biochemical or radiological evidence of rickets. Although we did not study an unsupplemented group, the lack of change in plasma 25-OHD levels reported by Wolf et al.,f and by Hillman and may be constraints on 25-hydroxylation in the preterm infant, a suggestion which has already been made with regard to adults requiring large vitamin D supplements.7 Although higher plasma 25-OHD concentrations were found at 36 weeks in group 2, the higher daily dose does not appear to have any advantages over the more conventional dose of 400 IU.
Our results show that preterm babies can absorb and 25-hydroxylate vitamin D3, but they do not exclude the possibility ofeither impaired 1 oc-hydroxylation of 25-OHD 8 or lack of end-organ response to 1,25-dihydroxyvitamin D3,9 either of which could cause rickets in the presence of a normal plasma 25-OHD concentration. In addition, calcium and phosphorus deficiency may sometimes be important aetiological factors. 10 We conclude that daily oral supplements of 400 IU of vitamin D3 are sufficient to produce normal plasma 25-OHD concentrations by 36 weeks in preterm babies.
We thank Professor J W Scopes for permission to study patients under his care. 
